Kharkov Academy of Postgraduate Education Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2007
NCT00528723
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Department of therapy of Kharkov Academy of Postgraduate Education, Kharkov, Ukraine | Kharkiv medical academy of postgraduate education

Active Ingredients

Drugs in Phase 3 Trials (2)

albuterol (proventil) (1 trial)

beclomethasone (vanceril) (1 trial)

Drugs in Phase 2 Trials (1)

gx-188e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Carcinoma in Situ (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3